Genocea Biosciences

+$0.13 (+6.31%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GNCA and other stocks, options, and ETFs commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. The firm uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.

CEO
William D. Clark
Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2006

GNCA Key Statistics

Market Cap
134.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
256.41K
High Today
$2.24
Low Today
$2.06
Open Price
$2.06
Volume
198.84K
52 Week High
$5.75
52 Week Low
$1.74

GNCA Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 22, Pre-Market

You May Also Like

BORR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure